Simulations Plus: Benefiting From FDA Modernization And AI

Group 1 - Simulations Plus, Inc. (NASDAQ: SLP) is a software company specializing in AI-based modeling and simulation tools aimed at accelerating pharmaceutical research for drug discovery and optimization [1] - The company utilizes pharmacology data to train its modeling systems, enhancing the efficiency of drug development processes [1]